Comparison Enliven Therapeutics (ELVN) with Competitors
Enliven Therapeutics (ELVN) industry is Biotechnology.
Free Cash Flow Yield
ELVN-2.02%
Industry-1.75%
Upside-0.28%
P/E
ELVN-32.12
Industry-20.52
Upside-1160.57%
P/B
ELVN8.15
Industry5.15
Upside+58.35%